首頁 > 市場調查報告書 > 食物/飲料

機能性食品

市場調查報告書

商品編碼

1455792

全球黃酮苷市場 - 2024-2031

Global Flavonoid Glycosides Market - 2024-2031

出版日期: 2024年03月26日 | 出版商:

DataM Intelligence | 英文 213 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球黃酮苷市場達到3.871億美元，預計2031年將達到6.406億美元，2024-2031年預測期間CAGR為6.5%。

由於對合成添加劑和人造物質的擔憂，消費者越來越偏好天然成分製成的產品。源自植物和水果的類黃酮苷順應了天然和清潔標籤產品的趨勢。因此，對含類黃酮苷產品的需求不斷增加，從而推動了市場成長。

正在進行的研究和開發工作的重點是探索類黃酮苷的健康益處和治療潛力。研究證明這些化合物具有抗氧化、抗發炎和抗菌特性，導致它們在藥品、營養保健品和功能性食品中的使用增加，從而擴大了黃酮苷在各行業的應用。

例如，2023年9月5日，贏創在SPACE 2023上推出了其單胃產品組合的新增強功能。它正在推出PhytriCare IM：贏創產品組合的最新成員，這種預混劑標誌著上鏡產品的首次亮相。它富含黃酮類化合物，可為母豬、蛋雞和乳牛的發炎管理提供潛在益處。

由於其抗氧化特性，類黃酮苷通常用作膳食補充劑中的活性成分。隨著消費者擴大轉向補充劑來滿足其營養需求，對含類黃酮苷補充劑的需求不斷增加，從而促進了市場成長。製造商透過推出由天然成分（包括類黃酮苷）製成的新產品來滿足消費者的喜好。對天然和清潔標籤產品的關注正在推動北美市場的成長。

動力學

對功能性食品和營養保健品的需求不斷成長

隨著消費者對功能性食品和營養保健品的健康益處的認知不斷增強，對富含類黃酮苷等生物活性化合物的產品的需求也相應增加。食品和飲料製造商可能會推出更多含有這些化合物的產品來滿足這項需求，從而擴大市場。

對功能性食品和營養保健品的需求鼓勵了食品產業的創新和產品開發。製造商不斷探索新的配方和輸送系統，以提高黃酮苷等生物活性化合物的生物利用度和功效。這項創新為消費者提供了更廣泛的產品選擇，從而推動了市場成長。

例如，2023 年 9 月 14 日，Uncle Matt's Organic 推出了「better-for-you」飲料系列的新成員：Superfruit Punch。它由黑甜櫻桃、黑接骨木漿果和藍莓混合製成，這種功能性果汁富含抗氧化劑、多酚和類黃酮。 Uncle Matt 的潘趣酒專為注重健康的消費者而設計，每 8 盎司僅含有 45 卡路里熱量，不添加糖或香料，也絕對不含防腐劑。

擴大在製藥業的應用

類黃酮苷傳統上因其治療特性而用於各種文化的草藥系統。隨著人們對自然療法和草藥補充劑的日益青睞，對含有類黃酮苷的藥品的需求也不斷增加。需求的增加直接促進了黃酮苷市場的成長。

製藥公司正在大力投資研發，探索黃酮苷的藥用特性及其在治療和預防各種疾病的潛在應用。例如，2024 年 2 月 29 日，Ingredients by Nature 宣佈在 BioFactors Journal 上發表其實驗研究，重點關注 Eriomin，一種獲得多項專利的柑橘類黃酮混合物。該研究深入探討了 Eriomin 促進肝功能和解決與年齡相關的肝臟問題的潛力。

原料供應有限

類黃酮苷主要來自水果、蔬菜和草藥等天然來源。氣候變遷、自然災害和季節變遷等因素可能會擾亂這些原料的供應鏈。原料供應中斷可能導致產量波動，影響市場成長。市場參與者面臨從多個地區採購原料的挑戰，導致供應短缺並阻礙市場成長。

含有黃酮苷的植物有特定的採收季節，此時原料豐富，品質最佳。原料供應量下降，導致維持穩定生產水準面臨挑戰。市場參與者需要儲存原料並投資儲存設施，以減輕季節性變化的影響，從而增加生產成本並可能影響市場成長。

Growing preference among consumers for products made with natural ingredients, driven by concerns about synthetic additives and artificial substances. Flavonoid glycosides, derived from plants and fruits, align with this trend toward natural and clean-label products. As a result, there is increasing demand for flavonoid glycoside-containing products, which is driving market growth.

Ongoing research and development efforts are focused on exploring the health benefits and therapeutic potential of flavonoid glycosides. Studies have demonstrated the antioxidant, anti-inflammatory, and antimicrobial properties of these compounds, leading to their increased use in pharmaceuticals, nutraceuticals, and functional foods expanding the applications of flavonoid glycosides in various industries.

For instance, on September 5, 2023, Evonik introduced new enhancements to its monogastric portfolio at SPACE 2023. It is introducing PhytriCare IM: Evonik's newest addition to the portfolio, this premix marks the debut of photogenic products. It is infused with flavonoids, it offers potential benefits in inflammation management for sows, laying hens, and dairy cows.

Flavonoid glycosides are commonly used as active ingredients in dietary supplements due to their antioxidant properties. As consumers increasingly turn to supplements to meet their nutritional needs, the demand for flavonoid glycoside-containing supplements is on the rise, contributing to market growth. Manufacturers are responding by introducing new products made with natural ingredients, including flavonoid glycosides, to cater to consumer preferences. This focus on natural and clean-label products is boosting market growth in North America.

Dynamics

Rising Demand for Functional Foods and Nutraceuticals

As consumer awareness about the health benefits of functional foods and nutraceuticals grows, there is a corresponding increase in demand for products enriched with bioactive compounds such as flavonoid glycosides. Food and beverage manufacturers are likely to introduce more products containing these compounds to cater to this demand, thereby expanding the market.

The demand for functional foods and nutraceuticals encourages innovation and product development within the food industry. Manufacturers are continually exploring new formulations and delivery systems to enhance the bioavailability and efficacy of bioactive compounds like flavonoid glycosides. This innovation fuels market growth by offering consumers a wider range of products to choose from.

For instance, on September 14, 2023, Uncle Matt's Organic introduced its new addition to the better-for-you beverage lineup: Superfruit Punch. It is crafted with a combination of dark sweet cherries, black elderberry, and blueberries, this functional juice is rich in antioxidants, polyphenols, and flavonoids. It is designed for health-conscious consumers, Uncle Matt's punch boasts just 45 calories per 8-oz serving, with no added sugars or flavors, and absolutely no preservatives.

Expanding Applications in the Pharmaceutical Industry

Flavonoid glycosides are traditionally used in herbal medicine systems across various cultures for their therapeutic properties. With the growing preference for natural remedies and herbal supplements, there is an increased demand for pharmaceutical products containing flavonoid glycosides. This increased demand directly contributes to the growth of the flavonoid glycosides market.

Pharmaceutical companies are investing heavily in research and development to explore the medicinal properties of flavonoid glycosides and their potential applications in the treatment and prevention of various diseases. For instance, on February 29, 2024, Ingredients by Nature announced the publication of its experimental research in the BioFactors Journal, focusing on Eriomin, a multi-patented citrus flavonoid blend. The study delves into the potential of Eriomin to promote liver function and address age-related liver concerns.

Limited Availability of Raw Materials

Flavonoid glycosides are primarily derived from natural sources such as fruits, vegetables, and herbs. Factors such as climate change, natural disasters, and seasonal variations can disrupt the supply chain of these raw materials. Interruption in the availability of raw materials can lead to fluctuations in production output, affecting market growth. Market players face challenges in sourcing raw materials from multiple regions, leading to supply shortages and hindering market growth.

The plants containing flavonoid glycosides have specific harvesting seasons, during which the raw materials are abundant and of optimal quality. The availability of raw materials declines, leading to challenges in maintaining consistent production levels. Market players need to stockpile raw materials and invest in storage facilities to mitigate the impact of seasonal variations, adding to production costs and potentially affecting market growth.

Segment Analysis

The global flavonoid glycosides market is segmented based on type, source, application, and region.

Increasing Demand for Antioxidant-Rich Products

Antioxidant holds the largest share of the global market. There is a growing awareness among consumers about the health benefits of antioxidants, including their role in neutralizing free radicals and reducing oxidative stress. As a result, there is a rising demand for antioxidant-rich products, such as dietary supplements, functional foods, and beverages, which contain flavonoid glycosides. This increased demand boosts market growth within the antioxidant segment.

Ongoing development focused on exploring the therapeutic potential of antioxidants in preventing and treating various diseases. Clinical studies investigating the efficacy of flavonoid glycosides and other antioxidants have generated promising results, further supporting their use in healthcare products. The positive outcomes of such research contribute to market growth within the antioxidant segment.

Geographical Penetration

Increasing Consumer Awareness and Innovations in North America

North America dominates the global flavonoid glycosides market. North America has a well-developed health and wellness industry, and consumers in the region are increasingly aware of the health benefits associated with flavonoid glycosides. There is a growing interest in natural and plant-based ingredients, including flavonoid glycosides, due to their antioxidant properties and potential health-promoting effects boosts demand for flavonoid glycoside-containing products in the region, contributing to market dominance.

North America has several major players in the food, beverage, dietary supplement, and pharmaceutical industries, which are actively involved in the production and distribution of flavonoid glycosides. These companies have extensive research and development capabilities, robust distribution networks, and strong brand recognition, enabling them to dominate the flavonoid glycosides market in the region.

COVID-19 Impact Analysis

The pandemic led to disruptions in global supply chains due to lockdown measures, travel restrictions, and workforce shortages. This disruption affected the sourcing of raw materials for flavonoid glycoside extraction, as well as the transportation of finished products. Consequently, market players faced challenges in maintaining production levels, leading to potential delays in product availability and fulfillment of orders, which could have hindered market growth.

The pandemic prompted significant shifts in consumer behavior, including changes in dietary preferences and purchasing patterns. With a heightened focus on health and wellness, consumers increasingly sought out products with immune-boosting and antioxidant properties, including those containing flavonoid glycosides. This shift in consumer demand could have bolstered market growth, as manufacturers responded by introducing new products or marketing existing ones emphasizing their flavonoid glycoside content.

Russia-Ukraine War Impact Analysis

During the conflict, disruptions occurred in the agricultural supply chains of both Russia and Ukraine, two significant exporters of raw materials used in flavonoid glycoside extraction. This disruption led to shortages and price volatility for raw materials, hindering production capabilities. Consequently, market growth was constrained due to reduced availability and increased production costs.

The conflict created geopolitical tensions and uncertainties, affecting trade relationships and international cooperation in the flavonoid glycosides market. Trade disruptions, tariffs, and export restrictions imposed by involved parties disrupted the flow of raw materials and finished products. This limited market access and increased trade barriers, negatively impacting market growth.

By Type

Quercetin-3-O-rutinoside (Q-rut)
Quercetin-3-O-galactoside (Q-gal)
Quercetin-3-O-glucoside (Q-glc)
Quercetin-3-O-glucuronide (Q-glr)
Kaempferol-3-O-glucoside (K-glc)
Others

By Source

Citrus Fruit
Buckwheat
Onions
Others

By Application

Anticancer
Antioxidant
Anti-inflammatory
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

On January 15, 2024, The Department of Food Chemistry and Biocatalysis at UPWr announced funding for its pioneering project through the 14th edition of the National Centre for Research and Development's "Leader" program. The innovative project, titled "Flavonoid Glycosides with a Chlorine Atom: Multifunctional, Natural Preserving Agents in Cosmetic Products," has been granted nearly 1.8 million PLN from the NCBR.
On December 12, 2023, Florida A&M University (FAMU) announced a groundbreaking discovery: flavonoids, natural compounds commonly found in fruits and vegetables, may present a promising new treatment avenue. It is the remarkable aspect of these compounds is their non-toxic nature and their potential to combat chemotherapy resistance in breast cancer patients.
On October 18, 2023, Taiyo's revolutionary enzymatic technology, the SunActive flavonoid delivery system, announced a significant leap forward for the dietary supplement industry. This patented, solvent-free innovation is enhancing the industry's capacity to introduce more potent and effective ingredients to the market, marking a significant advancement in product efficacy and quality.

Competitive Landscape

The major global players in the flavonoid glycosides market include Merck KGaA, Lifecare Neuro Products Limited, Indena S.p.A., Cayman Chemical Company, Extrasynthese, INDOFINE Chemical Company, Inc., SMPNutra, Taylor & Francis Group, LLC., Ayur-vana, and Ingredion Incorporated.

Why Purchase the Report?

To visualize the global flavonoid glycosides market segmentation based on type, source, application, and region, as well as understand critical commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous flavonoid glycosides market-level data points with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of critical products of all the major players.

The global flavonoid glycosides market report would provide approximately 62 tables, 57 figures, and 213 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1.Methodology and Scope

1.1.Research Methodology
1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

3.1.Snippet by Type
3.2.Snippet by Source
3.3.Snippet by Application
3.4.Snippet by Region

4.Dynamics

4.1.Impacting Factors
- 4.1.1.Drivers
  - 4.1.1.1.Rising Demand for Functional Foods and Nutraceuticals
  - 4.1.1.2.Expanding Applications in the Pharmaceutical Industry
- 4.1.2.Restraints
  - 4.1.2.1.Limited Availability of Raw Materials
- 4.1.3.Opportunity
- 4.1.4.Impact Analysis

5.Industry Analysis

5.1.Porter's Five Force Analysis
5.2.Supply Chain Analysis
5.3.Pricing Analysis
5.4.Regulatory Analysis
5.5.Russia-Ukraine War Impact Analysis
5.6.DMI Opinion

6.COVID-19 Analysis

6.1.Analysis of COVID-19
- 6.1.1.Scenario Before COVID
- 6.1.2.Scenario During COVID
- 6.1.3.Scenario Post COVID
6.2.Pricing Dynamics Amid COVID-19
6.3.Demand-Supply Spectrum
6.4.Government Initiatives Related to the Market During Pandemic
6.5.Manufacturers Strategic Initiatives
6.6.Conclusion

7.By Type

7.1.Introduction
- 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2.Market Attractiveness Index, By Type
7.2.Quercetin-3-O-rutinoside (Q-rut) *
- 7.2.1.Introduction
- 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3.Quercetin-3-O-galactoside (Q-gal)
7.4.Quercetin-3-O-glucoside (Q-glc)
7.5.Quercetin-3-O-glucuronide (Q-glr)
7.6.Kaempferol-3-O-glucoside (K-glc)
7.7.Others

8.By Source

8.1.Introduction
- 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 8.1.2.Market Attractiveness Index, By Source
8.2.Citrus Fruit*
- 8.2.1.Introduction
- 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3.Buckwheat
8.4.Onions
8.5.Others

9.By Application

9.1.Introduction
- 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2.Market Attractiveness Index, By Application
9.2.Anticancer*
- 9.2.1.Introduction
- 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3.Antioxidant
9.4.Anti-inflammatory
9.5.Others

10.By Region

10.1.Introduction
- 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2.Market Attractiveness Index, By Region
10.2.North America
- 10.2.1.Introduction
- 10.2.2.Key Region-Specific Dynamics
- 10.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1.U.S.
  - 10.2.6.2.Canada
  - 10.2.6.3.Mexico
10.3.Europe
- 10.3.1.Introduction
- 10.3.2.Key Region-Specific Dynamics
- 10.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1.Germany
  - 10.3.6.2.UK
  - 10.3.6.3.France
  - 10.3.6.4.Italy
  - 10.3.6.5.Russia
  - 10.3.6.6.Rest of Europe
10.4.South America
- 10.4.1.Introduction
- 10.4.2.Key Region-Specific Dynamics
- 10.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1.Brazil
  - 10.4.6.2.Argentina
  - 10.4.6.3.Rest of South America
10.5.Asia-Pacific
- 10.5.1.Introduction
- 10.5.2.Key Region-Specific Dynamics
- 10.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1.China
  - 10.5.6.2.India
  - 10.5.6.3.Japan
  - 10.5.6.4.Australia
  - 10.5.6.5.Rest of Asia-Pacific
10.6.Middle East and Africa
- 10.6.1.Introduction
- 10.6.2.Key Region-Specific Dynamics
- 10.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11.Competitive Landscape

11.1.Competitive Scenario
11.2.Market Positioning/Share Analysis
11.3.Mergers and Acquisitions Analysis

12.Company Profiles

12.1.Merck KGaA*
- 12.1.1.Company Overview
- 12.1.2.Product Portfolio and Description
- 12.1.3.Financial Overview
- 12.1.4.Key Developments
12.2.Merck KGaA
12.3.Lifecare Neuro Products Limited
12.4.Indena S.p.A.
12.5.Cayman Chemical Company
12.6.Extrasynthese
12.7.INDOFINE Chemical Company, Inc.
12.8.SMPNutra
12.9.Taylor & Francis Group, LLC.
12.10.Ayur-vana
12.11.Ingredion Incorporated [List not Exhaustive]